Seeking Alpha HealthcareOriginal article
Tilray reaffirms FY2027 adjusted EBITDA guidance of $68M-$75M while integrating BrewDog and preparing for Carlsberg deal
EarningsNeutral
AI Analysis
Summary
Tilray reaffirmed its FY2027 adjusted EBITDA guidance of $68M-$75M while proceeding with the integration of BrewDog and preparing for a deal with Carlsberg.
Financial Highlights
Guidance
$68M-$75M adjusted EBITDA for FY2027
Importance:3/10
Sentiment:
0.00
guidanceEBITDAM&AintegrationCarlsberg deal
Related Companies
Read the original article
Published by Seeking Alpha Healthcare on October 8, 2026 6:04 PM
